Different Immunological Requirements for Protection Against Acute versus Persistent Friend Retrovirus Infections
- 20 June 2000
- Vol. 272 (1), 177-182
- https://doi.org/10.1006/viro.2000.0356
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Weakened SIV Vaccine Still KillsScience, 1997
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal MacaquesScience, 1995
- Host-range control of a retroviral disease: Friend erythroleukemiaTrends in Microbiology, 1995
- Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptorNature, 1990
- Spi-1 is a putative oncogene in virally induced murine erythroleukaemiasNature, 1988
- Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia virusesVirology, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- Oncogenicity of friend-virus-infected cells: Determination of origin of spleen colonies by the H-2 antigens as genetic markersInternational Journal of Cancer, 1978
- HOST GENETIC CONTROL OF RECOVERY FROM FRIEND LEUKEMIA VIRUS-INDUCED SPLENOMEGALYThe Journal of Experimental Medicine, 1974